HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 342 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $854,467 | +27.3% | 15,017 | -11.5% | 0.00% | +33.3% |
Q3 2022 | $671,000 | -10.7% | 16,977 | -0.6% | 0.00% | 0.0% |
Q2 2022 | $751,000 | -6.4% | 17,073 | -15.1% | 0.00% | 0.0% |
Q1 2022 | $802,000 | -1.5% | 20,098 | -0.8% | 0.00% | 0.0% |
Q4 2021 | $814,000 | -1.0% | 20,251 | +0.2% | 0.00% | 0.0% |
Q3 2021 | $822,000 | -6.9% | 20,217 | +3.9% | 0.00% | 0.0% |
Q2 2021 | $883,000 | -0.1% | 19,452 | -8.3% | 0.00% | 0.0% |
Q1 2021 | $884,000 | -14.6% | 21,203 | -12.5% | 0.00% | -25.0% |
Q4 2020 | $1,035,000 | +47.2% | 24,228 | -9.4% | 0.00% | +33.3% |
Q3 2020 | $703,000 | -5.9% | 26,750 | -4.0% | 0.00% | -25.0% |
Q2 2020 | $747,000 | +57.3% | 27,866 | +5.5% | 0.00% | +33.3% |
Q1 2020 | $475,000 | +25.0% | 26,413 | +23.2% | 0.00% | +50.0% |
Q4 2019 | $380,000 | -42.9% | 21,443 | -68.9% | 0.00% | +100.0% |
Q4 2014 | $665,000 | +5.9% | 69,001 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $628,000 | -7.8% | 69,001 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $681,000 | -22.3% | 69,001 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $876,000 | -14.6% | 69,001 | +0.7% | 0.00% | -50.0% |
Q4 2013 | $1,026,000 | +35.9% | 68,501 | 0.0% | 0.00% | +100.0% |
Q3 2013 | $755,000 | +38.8% | 68,501 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $544,000 | – | 68,501 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |